ArticleOncology letters2018

Telocinobufagin inhibits the epithelial-mesenchymal transition of breast cancer cells through the phosphoinositide 3-kinase/protein kinase B/extracellular signal-regulated kinase/Snail signaling pathway.

Yuxue Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.